Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy

Fig. 1

Changes in metabolic indices in rats in the control, diabetes mellitus (DM), and diabetes mellitus + trimetazidine (DM + TMZ) groups (n = 5–6 per group). Changes in levels of total cholesterol (TC) (a), triglyceride (TG) (b), fasting blood glucose (FBG) (c), fasting insulin (FINS) (d), insulin sensitive index (ISI) (e), HDL-c (f) and LDL-c (g) are shown. Values are mean ± SEM. *p < 0.05 compared with control group; # p < 0.05 compared with diabetes group and & p < 0.05 compared with control group

Back to article page